Medici List

Core Molding Technologies, Inc. molds engineered thermoplastic and thermoset structural components for medium and heavy-duty trucks, powersports, building products and other industrial markets from six North American facilities headquartered in Columbus, Ohio.

3D Systems Corporation develops, manufactures and sells 3D printing and digital manufacturing solutions — including printers, materials, software and services — to healthcare and industrial customers globally.

ACCO Brands Corporation is a Delaware-incorporated global consumer, technology, and business branded products company that designs, sources, manufactures and sells well-known brands and product solutions for schools, homes and workplaces across primary markets including the United States, Europe, Australia, Canada, Brazil and Mexico.

Ares Strategic Income Fund (ASIF) is a Delaware statutory trust closed-end management investment company organized as a BDC that primarily originates and invests in U.S. middle‑market credit to generate current income and long‑term capital appreciation.

Castellum, Inc. is a technology services and products company providing cybersecurity, IT, electronic and information warfare, systems engineering, and mission support to U.S. defense, federal, and commercial clients.

Circle is a full‑stack, internet‑native financial platform anchored by regulated stablecoins (USDC, EURC) that provides reserve management, cross‑chain liquidity and interoperability, developer tools and the Arc blockchain, and institutional payment and custody services.

ALX Oncology is a clinical-stage biotechnology company developing cancer therapies (notably evorpacept and ALX2004) with no commercial products or product revenue to date.

BETA Technologies is a vertically integrated electric aircraft OEM that designs, manufactures, and sells piloted CTOL and VTOL aircraft, propulsion systems, batteries, and charging/GSE solutions for civil and defense customers.

Company name not provided — a pre-revenue company that reported no revenue in 2024 or 2025 and incurred net losses of $58,200,000 in 2025 and $65,363,000 in 2024; total assets were $157,059,000 and total stockholders' equity was $98,654,000 as of 2025.

ARS Pharmaceuticals develops and commercializes neffy, a FDA- and EC-approved needle-free intranasal epinephrine product for emergency treatment of anaphylaxis, commercialized in the U.S. and internationally through direct sales and partner collaborations.

908 Devices develops and sells handheld chemical analyzers that combine miniaturized mass spectrometry with FTIR/Raman spectroscopy and machine-learning analytics to provide rapid, point-of-need identification for first responders, government, and security customers.

Amplify Energy Corp is a public Delaware oil and gas company focused on acquisition, development and production of onshore and offshore oil and natural gas properties, currently concentrated on the Beta offshore (California) and Bairoil (Wyoming) assets.